Melniv-GP 300mg/500mcg Tablet
Manufacturer
Edward Young Labs
Salt Composition
Gabapentin (300mg) + Methylcobalamin (500mcg)
Key Information
Short Description
Melniv-GP 300mg/500mcg Tablet is a combination medicine used for the treatment of neuropathic pain. This medicine decreases pain by modulating calcium channel activity of the nerve cells.
Dosage Form
Tablet
Introduction
Melniv-GP 300mg/500mcg Tablet is taken by mouth with or without food, preferably at bedtime. It is advised to take medicine at the same time each day as this helps to maintain a consistent level of medicine in the body. Take this medicine in the dose and duration advised by your doctor. If you miss a dose of this medicine, take it as soon as you remember. Finish the full course of treatment even if you feel better. It is important that this medication is not stopped suddenly without talking to the doctor.
Directions for Use
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Melniv-GP 300mg/500mcg Tablet may be taken with or without food but it is better to take it at a fixed time.
How it works
Melniv-GP 300mg/500mcg Tablet is a combination of two medicines: Gabapentin and Methylcobalamin. Gabapentin is an alpha 2 delta ligand which decreases pain by modulating calcium channel activity of the nerve cells. Methylcobalamin is a form of vitamin B which helps in the production of myelin, a substance that protects nerve fibers and rejuvenates damaged nerve cells. Together, they relieve neuropathic pain (pain from damaged nerves).
Quick Tips
Rise slowly if you have been sitting or lying down. Avoid consuming alcohol when taking Melniv-GP 300mg/500mcg Tablet as it may cause excessive sleepiness. Inform your doctor if you develop any unusual changes in mood or behavior, new or worsening depression or suicidal thoughts or behavior. Do not stop taking the medication suddenly without talking to your doctor.
Related Medicines
Nervz-G Tablet
Gabaneuron Tablet
Gaba-Hosit Tablet
Pentanerv M Tablet
Nurokind-G Tablet
Gabapin ME Tablet
Mecofort G Tablet
Nuromark-G Tablet
Gabaget M 300mg/500mcg Tablet
Gabarev M 300mg/500mcg Tablet
Frequently asked questions
What is Melniv-GP 300mg/500mcg Tablet?
Melniv-GP 300mg/500mcg Tablet contains a combination of Gabapentin and Methylcobalamin. This medication is used to treat pain caused by nerve damage (peripheral neuropathy). It works by regenerating damaged nerves and reducing the pain sensation.
What is peripheral neuropathy?
Peripheral nerves, located outside the brain and spinal cord, carry messages from your brain and spine to the rest of your body. Peripheral neuropathy occurs when one or more of these nerves are damaged. This damage disrupts nerve function and communication between your central nervous system and your peripheral nervous system.
Can I stop taking Melniv-GP 300mg/500mcg Tablet once my pain is relieved?
No, continue taking Melniv-GP 300mg/500mcg Tablet for the entire prescribed duration. Your symptoms may improve before your nerves fully regenerate and heal.
Can Melniv-GP 300mg/500mcg Tablet cause sleepiness?
Yes, drowsiness is a common side effect of Melniv-GP 300mg/500mcg Tablet. Do not drive, operate machinery, or engage in activities requiring your full attention while taking this medication. Avoid drinking alcohol while on this medicine as it can worsen the effects of drowsiness and increase the risk of falls or accidents.
Can I take a higher dose of Melniv-GP 300mg/500mcg Tablet than recommended?
No, exceeding the recommended dosage of Melniv-GP 300mg/500mcg Tablet can increase the likelihood of side effects and toxicity. If your symptoms worsen despite standard doses, consult your doctor to re-evaluate your treatment plan.
What are the proper storage conditions for Melniv-GP 300mg/500mcg Tablet?
Store this medication in its original container or packaging. Keep it dry and protected from light, as directed on the label. Do not share this medicine with others and ensure that children, pets, or unauthorized individuals do not have access.
